Results 61 to 70 of about 35,538 (217)

Risk and protective factors for meningococcal disease in adolescents: matched cohort study [PDF]

open access: yes, 2006
Objective: To examine biological and social risk factors for meningococcal disease in adolescents. Design: Prospective, population based, matched cohort study with controls matched for age and sex in 1:1 matching.
Booth, C.   +9 more
core  

Risk of transmitting meningococcal infection by transient contact on aircraft and other transport. [PDF]

open access: yes, 2009
Contact tracing of persons with meningococcal disease who have travelled on aeroplane or other multi-passenger transport is not consistent between countries.
Hellenbrand, W   +4 more
core   +3 more sources

Serogroup W-135 Meningococcal Disease during the Hajj, 2000

open access: yesEmerging Infectious Diseases, 2003
An outbreak of serogroup W-135 meningococcal disease occurred during the 2000 Hajj in Saudi Arabia. Disease was reported worldwide in Hajj pilgrims and their close contacts; however, most cases were identified in Saudi Arabia.
Jairam R. Lingappa   +14 more
doaj   +1 more source

Serum bactericidal activity against circulating and reference strains of meningococcal serogroup B in the United States: A review of the strain coverage of meningococcal serogroup B (MenB) vaccines in adolescents and young adults

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Invasive meningococcal disease (IMD) is rare but associated with high morbidity and mortality. In the United States, the most vulnerable age groups are infants and adolescents/young adults, and the most common type of IMD is caused by serogroup B (MenB).
Jessica Presa   +4 more
doaj   +1 more source

Immunization strategies targeting newly arrived migrants in Non-EU countries of the mediterranean basin and black sea [PDF]

open access: yes, 2017
Background: The World Health Organization recommends that host countries ensure appropriate vaccinations to refugees, asylum seekers and migrants. However, information on vaccination strategies targeting migrants in host countries is limited. Methods: In
Declich, Silvia   +7 more
core   +1 more source

Efficacy and Safety of Crovalimab in Paroxysmal Nocturnal Hemoglobinuria (PNH): A Systematic Review and Meta‐Analysis

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Background Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, life‐threatening disorder characterized by complement‐mediated hemolysis. Crovalimab, a novel anti‐C5 monoclonal antibody, may offer a more convenient alternative to current therapies, highlighting the need for a comprehensive analysis of its efficacy and safety.
Hammad Javaid   +11 more
wiley   +1 more source

The human host defense peptide LL-37 interacts with Neisseria meningitidis capsular polysaccharides and inhibits inflammatory mediators release. [PDF]

open access: yesPLoS ONE, 2010
Capsular polysaccharides (CPS) are a major virulence factor in meningococcal infections and form the basis for serogroup designation and protective vaccines.
Susu M Zughaier   +4 more
doaj   +1 more source

Safety and efficacy of eculizumab in adult and pediatric patients with aHUS, with or without baseline dialysis [PDF]

open access: yes, 2015
C
Hourmant, Maryvonne   +5 more
core   +1 more source

Direct Switch From Iptacopan to Pegcetacoplan in a Patient With Paroxysmal Nocturnal Hemoglobinuria

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Introduction Paroxysmal nocturnal hemoglobinuria (PNH) is a rare clonal hematologic disorder treated with complement inhibitors. Currently, patients with suboptimal response to C5 inhibitors may be switched to proximal complement inhibitors, such as pegcetacoplan, danicopan, or iptacopan.
Vitalii Latyshev   +3 more
wiley   +1 more source

Fatal meningococcal meningitis in a HIV-infected patient caused by serogroup C Neisseria meningitidis belonging to the non-hypervirulent clonal complex ST-60 (cc60)

open access: yesBrazilian Journal of Infectious Diseases
Meningococcal strains belonging to clonal complex cc60 are not associated with hypervirulent lineages and were never reported as causing disease in Latin American countries.
Claudia Ferreira de Andrade   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy